People · Operator
Named in public records as an officer, director or promoter · active 2008–2016 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cerecin Inc. | — | Biotechnology | Series C | $162.0M | $34.1M | 2008 |
| ImmunoMolecular Therapeutics, Inc. | — | Biotechnology | Series A | $10.8M | $215.5M | 2015 |
| MicroBiome Therapeutics, LLC | — | Other Health Care | Seed | $3.1M | $18.4M | 2013 |
Steve Orndorff at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steve Orndorff on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jason Dinges | 1 | 8 |
| JOSEPH S. ZAKRZEWSKI | 1 | 6 |
| John Elstrott | 1 | 6 |
| Ross Barrett | 1 | 5 |
| Sean Doherty | 1 | 4 |
| Jonathan Behr | 1 | 4 |
| Dale Pfost | 1 | 3 |
| Thomas Werner | 1 | 3 |
| Tom Shea | 1 | 2 |
| Robert Schier | 1 | 2 |
| Dean P. Stull | 1 | 2 |
| John B. Elstrott | 1 | 2 |
| Gunnar Weikert | 1 | 2 |
| Mark Heiman | 1 | 2 |
| Gunnar H Weikert | 1 | 1 |
| Luis H Cantarell | 1 | 1 |
| Claude H Nash | 1 | 1 |
| Holger Kunze | 1 | 1 |
| Richard B. Montgomery | 1 | 1 |
| Ross R. Barrett | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.